Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter

Biochemistry and Cell Biology

Volumn 76, Issue 5, 1998, Pages 695-708

  Sharom, Frances J ^a   Liu, Ronghua ^a   Romsicki, Yolanda ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Circular dichroism spectroscopy; Differential scanning calorimetry; Electron microscopy; Fluorescence spectroscopy; Infra red spectroscopy; Multidrug resistance; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMIDE; BEAUVERICIN; COLCHICINE; CYCLOSPORIN A; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FLUPENTIXOL; GLYCOPROTEIN P; GRAMICIDIN D; LEUPEPTIN; NEW DRUG; NONACTIN; PACLITAXEL; PEPSTATIN; PROGESTERONE; QUINIDINE; RESERPINE; RHODAMINE 123; TOPOTECAN; TRIFLUOPERAZINE; TRITON X 100; VALINOMYCIN; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANALYTIC METHOD; BINDING KINETICS; BINDING SITE; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG PROTEIN BINDING; DRUG TRANSPORT; ENZYME ACTIVITY; FLUORESCENCE SPECTROSCOPY; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0032461892     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o98-075     Document Type: Conference Paper

References (71)

1. al-Shawi, M.K., Urbatsch, I.L., and Senior, A.E. 1994. Covalent inhibitors of P-glycoprotein ATPase activity. J. Biol. Chem. 269: 8986-8992.
2. Baubichon-Cortay, H., Baggetto, L.G., Dayan, G., and Di Pietro, A. 1994. Overexpression and purification of the carboxyl-terminal nucleotide-binding domain from mouse P-glycoprotein. Strategic location of a tryptophan residue. J. Biol. Chem. 269: 22983-22989.
3. Biancet, M.A., Ko, Y.H., Amzel, L.M., and Pedersen, P.L. 1997. Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR). J. Bioenerg. Biomembr. 29: 503-524.
4. Bosch, I., and Croop, J. 1996. P-glycoprotein multidrug resistance and cancer. Biochim. Biophys. Acta, 1288: F37-F54.
5. Callaghan, R., Berridge, G., Ferry, D.R., and Higgins, C.F. 1997. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. Biochim. Biophys. Acta, 1328: 109-124.
6. Chicken, C.A., and Sharom, F.J. 1984. Lipid-protein interactions of the human erythrocyte concanavalin A receptor in phospholipid bilayers. Biochim. Biophys. Acta, 774: 110-118.
7. Dayan, G., Baubichon-Cortay, H., Jault, J.M., Cortay, J.C., Deleage, G., and Di Pietro, A. 1996. Recombinant N-terminal nucleotide-binding domain from mouse P-glycoprotein. Overexpression, purification, and role of cysteine 430. J. Biol. Chem. 271: 11652-11658.
8. Dayan,G., Jalt, J.M., Baubichon-Cortay, H., Baggetto, L.G., Renoir, J.M., Baulieu, E.E., Gros, P., and Di Pietro, A. 1997. Binding of steroid modulators to recombinant cytosolic domain from mouse P-glycoprotein in close proximity to the ATP site. Biochemistry, 36: 15208-15215.
9. Dewey,T.G., and Hammes, G.G. 1980. Calculation on fluorescence resonance energy transfer on surfaces. Biophys. J. 32: 1023-1035.
10. Dey, S., Ramachandra, M., Pastan, I., Gottesman, M.M., and Ambudkar, S.V. 1997. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 94: 10594-10599.
11. DiDiodto, G., and Sharom, F.J. 1997. Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter. Biochem. Pharmacol. 53: 1789-1797.
12. Doige, C.A., and Ames, G.F. 1993. ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu. Rev. Microbiol. 47: 291-319.
13. Doige, C.A., and Sharom, F.J. 1992. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta, 1109: 161-171.
14. Doige, C.A., Yu, X., and Sharom, F.J. 1992. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta, 1109: 149-160.
15. Doige, C.A., Yu, X., and Sharom, F.J. 1993. The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim. Biophys. Acta, 1146: 65-72.
16. Dong, M., Penin, F., and Baggetto, L.G. 1996. Efficient purification and reconstitution of P-glycoprotein for functional and structural studies. J. Biol. Chem. 271: 28875-28883.
17. Dong, M., Ladvière, L., Penin, F., Deléage, G., and Baggetto, L.G. 1998. Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysis. Biochim. Biophys. Acta, 1371: 317-334.
18. Eytan, G.D., Borgnia, M.J., Regev, R., and Assaraf, YG. 1994. Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein. J. Biol. Chem. 269: 26058-26065.
19. Eytan, G.D., Regev, R., and Assaraf, Y.G. 1996. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem. 271: 3172-3178.
20. George, R., Lewis, R.N., and McElhaney, R.N. 1990. Studies on the purified Na+,Mg(2+)-ATPase from Acholeplasma laidlawii B membranes: a differential scanning calorimetric study of the protein-phospholipid interactions. Biochem. Cell Biol. 68: 161-168.
21. Georges, E., Sharom, F.J., and Eing, V. 1990. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv. Pharmacol. 21: 185-220.
22. Germann, U.A. 1996. P-glycoprotein: a mediator of multidrug resistance in tumour cells. Eur. J. Cancer, 32A: 927-944.
23. Higgins, C.F. 1992. ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol. 8: 67-113.
24. Higgins, C.F., and Gottesman, M.M. 1992. Is the multidrug transporter a flippase? Trends Biochem. Sci. 17: 18-21.
25. Higgins, C.F., Callaghan, R., Linton, K.J., Rosenberg, M.F., and Ford, R.C. 1997. Structure of the multidrug resistance P-glycoprotein. Semin. Cancer Biol. 8: 135-142.
26. Hoedemaeker, F.J., Davidson, A.R., and Rose, D.R. 1998. A model for the nucleotide-binding domains of ABC transporters based on the large domain of aspartate aminotransferase. Proteins, 30: 275-286.
27. Hung, L.-W., Wang, I.X., Nikaido, K., Liu, P.-Q., Ferro-Luzzi Ames, G., and Kim, S.-H. 1998. Crystal structure of the ATP-binding subunit of an ABC transporter. Nature (London), 396: 703-707.
28. Hyde, S.C., Emsley, P., Hartshorn, M.J., Mimmack, M.M., Gileadi, U., Pearce, S.R., Gallagher, M.P., Gill, D.R., Hubbard, R.E., and Higgins, C.F. 1990. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature (London), 346: 362-365.
29. Karkaria, C.E., and Rosen, B.P. 1991. Trinitrophenyl-ATP binding to the ArsA protein: the catalytic subunit of an anion pump. Arch. Biochem. Biophys. 288: 107-111.
30. Kast, C., Canfield, V., Levenson, R., and Gros, P. 1996. Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J. Biol. Chem. 271: 9240-9248.
31. Ko, Y.H., Thomas, P.J., Delannoy, M.R., and Pedersen, P.L. 1993. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J. Biol. Chem. 268: 24330-24338.
32. Koppel, D.E., Fleming, P.J., and Strittmatter, P. 1979. Intramembrane positions of membrane-bound chromophores determined by excitation energy transfer. Biochemistry, 18: 5450-5457.
33. Li, J., and Rosen, B.P. 1998. Steric limitations in the interaction of the ATP binding domains of the ArsA ATPase. J. Biol. Chem. 273: 6796-6800.
34. Li, J., Liu, S., and Rosen, B.P. 1996. Interaction of ATP binding sites in the ArsA ATPase, the catalytic subunit of the Ars pump. J. Biol. Chem. 271: 25247-25252.
35. Liu, R., and Sharom, F.J. 1996. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry, 35: 11865-11873.
36. Liu, R., and Sharom, F.J. 1997. Fluorescence studies on the nucleotide binding domains of the P-glycoprotein multidrug transporter. Biochemistry, 36: 2836-2843.
37. Liu, R., and Sharom, F.J. 1998. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study. Biochemistry, 37: 6503-6512.
38. Loo, T.W., and Clarke, D.M. 1994. Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. J. Biol. Chem. 269: 7750-7755.
39. Loo, T.W., and Clarke, D.M. 1995a. Membrane topology of a cysteine-less mutant of human P-glycoprotein. J. Biol. Chem. 270: 843-848.
40. Loo, T.W., and Clarke, D.M. 1995b. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J. Biol. Chem. 270: 22957-22961.
41. Loo, T.W., and Clarke, D.M. 1996. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. J. Biol. Chem. 271: 27482-27487.
42. Loo, T.W., and Clarke, D.M. 1997a. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. J. Biol. Chem. 272: 20986-20989.
43. Loo, T.W., and Clarke, D.M. 1997b. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. J. Biol. Chem. 272: 31945-31948.
44. Mao, Q., and Scarborough, G.A. 1997. Purification of functional human P-glycoprotein expressed in Saccharomyces cerevisiae. Biochim. Biophys. Acta, 1327: 107-118.
45. Mimura, C.S., Holbrook, S.R., and Ames, G.F. 1991. Structural model of the nucleotide-binding conserved component of periplasmic permeases. Proc. Natl. Acad. Sci. U.S.A. 88: 84-88.
46. Naderi, S., Doyle, K., and Melchior, D.L. 1995. Preferential association of membrane phospholipids with the human erythrocyte hexose transporter. Biochim. Biophys. Acta, 1236: 10-14.
47. Ramachandra, M., Ambudkar, S.V., Chen, D., Hrycyna, C.A., Dey, S., Gottesman, M.M., and Pastan, I. 1998. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry, 37: 5010-5019.
48. Randak, C., Roscher, A.A., Hadorn, H.B., Assfalg-Machleidt, I., Auerswald, E.A., and Machleidt, W. 1995. Expression and functional properties of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator fused to glutathione-S-transferase. FEBS Lett. 363: 189-194.
49. Romsicki, Y., and Sharom, F.J. 1997. Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study. Biochemistry, 36: 9807-9815.
50. Romsicki, Y., and Sharom, F.J. 1998. The ATPase and ATP binding functions of P-glycoprotein: modulation by interaction with defined phospholipids. Eur. J. Biochem. 256: 170-178.
51. Rosenberg, M.F., Callaghan, R., Ford, R.C., and Higgins, C.F. 1997. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272: 10685-10694.
52. Ruetz, S., and Gros, P. 1994. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell, 77: 1071-1081.
53. Safa, A.R., Stern, R.K., Choi, K., Agresti, M., Tamai, I., Mehta, N.D., and Roninson, I.B. 1990. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185 to Val-185 substitution in P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 87: 7225-7229.
54. Senior, A.E., and Gadsby, D.C. 1997. ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. Semin. Cancer Biol. 8: 143-150.
55. Senior, A.E., al-Shawi, M.K., and Urbatsch, I.L. 1995a. The catalytic cycle of P-glycoprotein. FEBS Lett. 377: 285-289.
56. Senior, A.E., al-Shawi, M.K., and Urbatsch, I.L. 1995b. ATP hydrolysis by multidrug-resistance protein from Chinese hamster ovary cells. J. Bioenerg. Biomembr. 27: 31-36.
57. Shapiro, A.B., and Ling, V. 1994. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269: 3745-3754.
58. Shapiro, A.B., and Ling, V. 1995. Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270: 16167-16175.
59. Shapiro, A.B., and Ling, V. 1997. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250: 130-137.
60. Sharma, S., and Rose, D.R. 1995. Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein. J. Biol. Chem. 270: 14085-14093.
61. Sharom, F.J. 1997a. The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160: 161-175.
62. Sharom, F.J. 1997b. The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity. Biochem. Soc. Trans. 25: 1088-1096.
63. Sharom, F.J., Yu, X., and Doige, C.A. 1993. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268: 24197-24202.
64. Sharom, F.J., DiDiodato, G., Yu, X., and Ashbourne, K.J. 1995a. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. J. Biol. Chem. 270: 10334-10341.
65. Sharom, F.J., Yu, X., Chu, J.W.K., and Doige, C.A. 1995b. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem. J. 308: 381-390.
66. Sharom, F.J., Yu, X., DiDiodato, G., and Chu, J.W.K. 1996. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem. J. 320: 421-428.
67. Sharom, F.J., Lu, P., Liu, R., and Yu, X. 1998. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. Biochem. J. 333: 621-630.
68. Sharom, F.J., Yu, X., Lu, P., Liu, R., Chu, J.W.K, Szabó, K., Müller, M., Hose, C.D., Monks, A., Váradi, A., Sepródi, di, J., and Sarkadi, B. 1999. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems and intact cells. Biochem. Pharmacol. In press.
69. Sonveaux, N., Shapiro, A.B., Goormaghtigh, E., Ling, V., and Ruysschaert, J.M. 1996. Secondary and tertiary structure changes of reconstituted P-glycoprotein. A Fourier transform attenuated total reflection infrared spectroscopy analysis. J. Biol. Chem. 271: 24617-24624.
70. Urbatsch, I.L., al-Shawi, M.K., and Senior, A.E. 1994. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry, 33: 7069-7076.
71. Urbatsch, I.L., Beaudet, L., Carrier, I., and Gros, P. 1998. Mutations in either nucleotide-binding site of P-glycoprotein (mdr3) prevent vanadate trapping of nucleotide at both sites. Biochemistry, 37: 4592-4602.